Tyler Maddry

As co-head of the firm’s intellectual property practice group, Tyler focuses his practice on complex intellectual property and technology contracts. Tyler represents clients ranging from Fortune 100 companies to startups in structuring, drafting and negotiating complex intellectual property and technology contracts, including patent and technology license agreements, joint development agreements, AI services agreements, software licenses, data licensing, master services agreements, software as a service (SaaS) agreements, API license agreements, technology escrow agreements, trademark license agreements, university license agreements, and IP and technology transfer agreements. He also has extensive experience in structuring and negotiating IP and technology provisions in M&A transactions, conducting IP and IT due diligence investigations, advising on open source software compliance, litigation of intellectual property rights, and resolution of IP and technology contract disputes. His practice covers a range of industries, including artificial intelligence, energy, life sciences, and fintech.

Tyler is a member of the Licensing Executives Society and is admitted to practice before the US Court of Appeals for the Federal Circuit and the US District Courts for the Eastern District of Virginia and Eastern District of Texas. He is also registered with the US Patent and Trademark Office.

• Regularly represents major companies in structuring and negotiating IP and technology terms in M&A and corporate transactions, including asset purchase agreements, stock purchase agreements, and merger agreements, drafting and negotiating associated IP and technology license agreements and IP assignments, and conducting IP and IT due diligence investigations.
• Regularly represents institutional clients in negotiating AI services agreements against leading AI providers, including terms for protection of company data, IP ownership, and IP infringement indemnification.
• Represents clients in development and deployment of customized AI systems, including licensing of company proprietary data to third party AI providers, copyright fair use risk assessments, acceptable use of retrieval augmented generation (RAG), and labeling of AI-generated content.
• Represents global life sciences and diagnostics company in negotiating agreements with AI model providers for molecular discovery and laboratory automation with agentic AI.
• Represents nuclear innovation company in drafting and negotiating technology license and collaboration agreements, subrecipient agreements, and subcontracts for development and commercialization of next generation sodium fast reactors and molten chloride fast reactors with industrial collaboration partners under US Department of Energy cooperative agreements.
• Represented CHIPS Program Office of the US Department of Commerce in connection with its $1.5 billion direct funding award to GlobalFoundries under the CHIPS Incentive Program’s Funding Opportunity for Commercial Fabrication Facilities.
• Represented global life sciences and diagnostics company in negotiating numerous agreements with leading universities and research institutions for development of next generation technologies including digital biomarkers for neurosurgery, phenotyping engine using AI models for drug screening, CRISPR gene editing for treatment of rare diseases, sepsis subtyping based on gene expression using AI models, prediction of breast cancer HER2 antibody-drug conjugate treatment response, and diagnosis and monitoring of traumatic brain injury.
• Drafted client policies and procedures for use of generative AI, including permitted and prohibited AI systems and use cases, restrictions on use of company proprietary data and AI-generated output, formation of cross-functional AI committee, employee AI training, AI vendor management and model AI contract terms, verification and approval of AI-generated output, and labeling of AI-generated images.
• Represented Societatea Nationala Nuclearelectrica S.A. (SNN) in connection with a complex and highly bespoke engineering, procurement, and construction (EPC) contract for the provision of the retubing, refurbishment, and infrastructure works for Unit 1 of the Cernavodă nuclear power plant in Cernavodă, Romania.
• Represented RoPower Nuclear S.A. in connection with the deployment of the NuScale VOYGR-6 power Small Modular Reactor (SMR) generation facility in Doiceşti, Romania.
• Represented medical device manufacturer in negotiation of agreements for development and commercialization of imaging devices incorporating machine learning models for applying virtual stains to tissue sample images and for diagnosis of cancer in medical images.

• Represented 3D printer manufacturer in drafting and negotiation of IP and technology license agreements, IP terms in M&A transactions, and joint development, technology escrow, and end user agreements relating to 3D printers and integrated technologies and services for industrial and life sciences applications.
• Represented developer of cybersecurity technology for electric grid in drafting and negotiation of IP and technology license agreements for development and deployment of cybersecurity technology.
• Represented independent system operator in drafting and negotiation of master services agreement using agile development model and open source software for development of energy data platform for energy market participants.
• Represented patent licensor against leading pharma company in negotiation of settlement of royalty dispute relating to patents on lipase inhibitors for treatment of obesity.
• Represented startup against major pharma company in negotiation of patent license for PCSK9 inhibitors relating to cholesterol reduction.
• Represented medical device manufacturer in drafting and negotiating development agreement, quality agreement, and trademark license for the international development and commercialization of technology relating to fluorescent in situ hybridization (FISH) probes for cancer detection.
• Represented Fortune 100 company in drafting and negotiating international research collaboration agreement relating to imaging agents comprising proprietary compounds for the detection of Alzheimer’s disease.
• Represented Fortune 100 company in drafting and negotiating license agreement relating to imaging agents comprising proprietary peptides for cancer detection.
• Represented IT, cloud, and cybersecurity services company in licensing and protection of its technology and intellectual property and in resolution of numerous contract disputes.
• Represented manufacturer of magnetic resonance imaging (MRI) machines in patent appeal and worldwide licensing and settlement negotiations.
• Represented Fortune 100 company in negotiation of international license agreement relating to locomotive technology.
• Drafted and negotiated numerous agreements for domestic and international development and licensing of intellectual property rights, including patent, technology, AI, software, data, and trademark license agreements.
• Prepared formal opinions on patent validity, enforceability, and infringement.
• Conducted patent clearance studies to identify potential infringement issues for new product introductions.

• Recommended for Patents: Licensing (2019-2021, 2025), Patents: Litigation (Full Coverage) (2019-2020), Patents: Prosecution (2019), Technology Transactions (2019, 2023-2024), Trademarks: Litigation (2021-2025), and Trademarks: Non-Contentious (2021-2025), Legal 500 United States
• Recommended for Patent Transactions in Washington, DC in the IAM Patent 1000 (2022-2025), Intellectual Asset Management

• Recognized as a Patent Star in the IP STARS Handbook (2025), Managing Intellectual Property

• Member, Licensing Executives Society